NATHBIOGEN

Basic MaterialsAgricultural InputsMicro Cap
Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited (NATHBIOGEN), operating in the Basic Materials sector under Agricultural Inputs, produces, processes, and markets hybrid and GM seeds in India and in...

हिन्दी में

Nath Bio-Genes (India) Limited (NATHBIOGEN), जो बेसिक मटीरियल्स सेक्टर के अंतर्गत एग्रीकल्चरल इनपुट्स में कार्यरत है, भारत और अंतरराष्ट्रीय स्तर पर हाइब्रिड और जीएम बीजों का उत्पाद...

₹136.87-1.04%1D
Previous trading day close · Data updates after market close
1W: -4.2%
1M: -10.3%
6M: -7.5%
1Y: -16.9%
68/100
AverageResearch Score
Market Cap
₹321 Cr
Micro Cap
P/E Ratio
7.43
Below avg
P/B Ratio
0.45
Reasonable
ROE
6.2%
Weak
ROCE
8.8%
Average
Debt / Equity
0.20
Low debt
Div. Yield
1.4%
Low yield
EV/EBITDA
5.58
Attractive
52W Low: ₹126.15Current: ₹136.8752W High: ₹204
At 14% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
51/100
Growth
Revenue, EPS, profit growth
66/100
Valuation
PE, PB, EV/EBITDA vs sector
92/100
Risk
Debt levels, volatility, coverage
90/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
7.43(Below avg)
Forward P/E
N/A
P/B Ratio
0.45(Reasonable)
P/S Ratio
0.53(Good)
EV/EBITDA
5.58(Attractive)
Dividend Yield
1.4%
5Y CAGR
-15.3%(Moderate)
Revenue Growth
15.8%(Moderate)
Profitability
ROE
6.2%(Average)
ROCE
8.8%(Average)
ROA
4.1%(Average)
Net Margin
9.3%(Decent)
EBITDA Margin
14.7%
Financial Health
Debt to Equity
0.20(Low debt)
Current Ratio
1.89(Healthy)
Quick Ratio
0.96(Tight)
Interest Coverage
4.04x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
37(Neutral)
RSI Exp (14)
27(Oversold)
MACD
-4.301(Bearish)
MACD Signal
-3.335
BB Position
9%(Lower band)
BB Width
15.00%(Normal)
ADX (14)
39.0(Strong trend)
Williams %R
-82.3(Oversold)
MFI (14)
64(Neutral)
CCI (20)
-144(Oversold)
Stoch %K
18(Oversold)
ATR (14)
6.02(Avg True Range)
OBV (M)
0.8(Positive)
1W OBV Chg
-2.4%(Decreasing)
Rel Volume
0.38x(Low activity)
Volatility
35.9%(Moderate)
Max DD 1Y
-45.1%(High loss)
Alpha (CAPM)
-9.41%(Underperforming)
Return vs Nifty
-6.9%(Below Nifty)
EMA 200
158.8
EMA 50
150.8
SMA 200
156.3
vs SMA 50
-10.1%(Below SMA50)
vs SMA 200
-12.4%(Below SMA200)
Volume
7.1K
Avg Vol 3M
0.2L
Shareholding Pattern
Promoter
45.6%
Moderate
FII
0.2%
DII / MF
0.0%
Share NATHBIOGEN
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.